LPA1 antagonist, LPA1 antagonist, Placebo for BMS-986278
IM027068
Phase 3 small_molecule active
Quick answer
LPA1 antagonist, LPA1 antagonist, Placebo for BMS-986278 for Idiopathic pulmonary fibrosis is a Phase 3 program (small_molecule) at Bristol-Myers Squibb / Pfizer EEIG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb / Pfizer EEIG
- Indication
- Idiopathic pulmonary fibrosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active